Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01621490 |
|---|---|
| Brief Title: | PH 1 Biomarker Study of Nivolumab and Ipilimumab and Nivolumab in Combination With Ipilimumab in Advanced Melanoma (PD-1) |
| First Submitted : | June 14, 2012 |
| First Submitted that Met QC Criteria : | June 15, 2012 |
| First Posted : | June 18, 2012 (Estimate) |
| Results First Submitted : | September 12, 2018 |
| Results First Submitted that Met QC Criteria : | November 14, 2019 |
| Results First Posted : | December 3, 2019 |
| Last Update Submitted that Met QC Criteria : | November 14, 2019 |
| Last Update Posted : | December 3, 2019 |